Estrogen-related genes and their contribution to racial differences in breast cancer risk

Cancer Causes and Control

Volumn 23, Issue 5, 2012, Pages 671-681

  Reding, Kerryn W ^a,b   Chen, Chu ^a,b   Lowe, Kimberly ^c   Doody, David R ^a   Carlson, Christopher S ^a,b   Chen, Christina T ^a   Houck, John ^a   Weiss, Linda K ^d   Marchbanks, Polly A ^e   Bernstein, Leslie ^f   Spirtas, Robert ^g   McDonald, Jill A ^e   Strom, Brian L ^h   Burkman, Ronald T ⁱ   Simon, Michael S ^j   Liff, Jonathan M ^k   Daling, Janet R ^a   Malone, Kathleen E ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c EXPONENT INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ Baystate Health ^*  (United States)

^j WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k EMORY UNIVERSITY   (United States)

more..

Author keywords

Breast cancer; Gene environment interactions; Genetic variation; Hormone therapy; Racial disparities

Indexed keywords

AROMATASE; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 17; CYTOCHROME P450 17A1; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; ESTRADIOL 17 BETA DEHYDROGENASE 1; ESTRADIOL 17BETA DEHYDROGENASE; ESTROGEN RECEPTOR ALPHA; GLUCURONOSYLTRANSFERASE 1A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; SULFOTRANSFERASE 1A1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CAUCASIAN; COMT GENE; CONTROLLED STUDY; CYP17A1 GENE; CYP19A1 GENE; CYP1A1 GENE; CYP1B1 GENE; DISEASE ASSOCIATION; ESR1 GENE; ESTROGEN METABOLISM; ESTROGEN RELATED GENES; FEMALE; GENETIC VARIABILITY; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HAPLOTYPE; HORMONAL THERAPY; HSD17B1 GENE; HUMAN; MAJOR CLINICAL STUDY; NEGRO; ONCOGENE; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SULT1A1 GENE; UGT1A1 GENE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGENS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84862780410     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9925-x     Document Type: Article

References (74)

1. Amend K, Hicks D, Ambrosone CB (2006) Breast cancer in African-American women: differences in tumor biology from European-American women. Cancer Res 66:8327-8330 (Pubitemid 44449138)
2. Morris GJ, Mitchell EP (2008) Higher incidence of aggressive breast cancers in African-American women: a review. J Natl Med Assoc 100:698-702 (Pubitemid 351874447)
3. Li CI, Malone KE, Daling JR (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11:601-607 (Pubitemid 34760817)
4. Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492-2502 (Pubitemid 43854964)
5. Jones BA, Kasl SV, Howe CL et al (2004) African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer 101:1293-1301 (Pubitemid 39180384)
6. Joe AK, Hibshoosh H (2005) African-American/White differences in breast carcinoma. Cancer 104:661-662
7. Simon MS, Korczak JF, Yee CL et al (2006) Breast cancer risk estimates for relatives of white and African American women with breast cancer in the Women's Contraceptive and Reproductive Experiences Study. J Clin Oncol 24:2498-2504 (Pubitemid 46630626)
8. Chlebowski RT, Chen Z, Anderson GL et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439-448
9. Huo D, Ikpatt F, Khramtsov A et al (2009) Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 27:4515-4521
10. Gapstur SM, Morrow M, Sellers TA (1999) Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. JAMA 281:2091-2097
11. Millikan RC, Newman B, Tse CK et al. (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123-139 (Pubitemid 351538762)
12. Hall P, Ploner A, Bjohle J et al (2006) Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study. BMC Med 4:16
13. Biglia N, Sgro L, Defabiani E et al (2005) The influence of hormone replacement therapy on the pathology of breast cancer. Eur J Surg Oncol 31:467-472 (Pubitemid 40724085)
14. Phipps AI, Chlebowski RT, Prentice R et al (2011) Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 103:470-477
15. Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 113:1521-1526
16. Brett KM, Madans JH (1997) Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 145:536-545 (Pubitemid 27111222)
17. Setiawan VW, Haiman CA, Stanczyk FZ, Le ML, Henderson BE (2006) Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 15:1849-1855 (Pubitemid 44664259)
18. Pinheiro SP, Holmes MD, Pollak MN, Barbieri RL, Hankinson SE (2005) Racial differences in premenopausal endogenous hormones. Cancer Epidemiol Biomarkers Prev 14:2147-2153 (Pubitemid 41603260)
19. Haiman CA, Pike MC, Bernstein L et al (2002) Ethnic differences in ovulatory function in nulliparous women. Br J Cancer 86:367-371 (Pubitemid 34185119)
20. Randolph JF Jr, Sowers M, Bondarenko IV, Harlow SD, Luborsky JL, Little RJ (2004) Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 89:1555-1561 (Pubitemid 38507902)
21. Sowers MR, Jannausch ML, McConnell DS, Kardia SR, Randolph JF Jr (2006) Endogenous estradiol and its association with estrogen receptor gene polymorphisms. Am J Med 119:S16-S22 (Pubitemid 44292098)
22. Beckmann L, Husing A, Setiawan VW et al (2011) Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3). J Clin Endocrinol Metab 96:E360-E367
23. Friedenreich CM (2001) Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 10:15-32
24. Kato I, Cichon M, Yee CL, Land S, Korczak JF (2009) African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer. Cancer Epidemiol 33:24-30
25. Rebbeck TR, Troxel AB, Walker AH et al (2007) Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. Cancer Epidemiol Biomarkers Prev 16:444-450 (Pubitemid 46548647)
26. Taioli E, Trachman J, Chen X, Toniolo P, Garte SJ (1995) A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 55: 3757-3758
27. Van Emburgh BO, Hu JJ, Levine EA et al (2008) Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer. Oncol Rep 19:1311-1321
28. Bryc K, Auton A, Nelson MR et al (2010) Genome-wide patterns of population structure and admixture in West Africans and African Americans. Proc Natl Acad Sci U S A 107:786-791
29. Fejerman L, Haiman CA, Reich D et al (2009) An admixture scan in 1,484 African American women with breast cancer. Cancer Epidemiol Biomarkers Prev 18:3110-3117
30. Tishkoff SA, Reed FA, Friedlaender FR et al (2009) The genetic structure and history of Africans and African Americans. Science 324:1035-1044
31. Sexton KR, Franzini L, Day RS, Brewster A, Vernon SW, Bondy ML (2011) A review of body size and breast cancer risk in Hispanic and African American women. Cancer 117:5271-5281
32. Marchbanks PA, McDonald JA, Wilson HG et al (2002) The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol 12:213-221 (Pubitemid 34414934)
33. Rothman KJ (1986) Modern epidemiology, 1st edn. Little, Brown and Co, Boston
34. Greenland S, Thomas DC (1982) On the need for the rare disease assumption in case-control studies. Am J Epidemiol 116:547-553
35. Miettinen O (1976) Estimability and estimation in case-referent studies. Am J Epidemiol 103:226-235
36. Lavigne JA, Helzlsouer KJ, Huang HY et al (1997) An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 57:5493-5497 (Pubitemid 28006754)
37. Hayashi S, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem 110:407-411
38. Holt SK, Rossing MA, Malone KE, Schwartz SM, Weiss NS, Chen C (2007) Ovarian cancer risk and polymorphisms involved in estrogen catabolism. Cancer Epidemiol Biomarkers Prev 16:481-489 (Pubitemid 46553577)
39. Crofts F, Cosma GN, Currie D, Taioli E, Toniolo P, Garte SJ (1993) A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis 14:1729-1731 (Pubitemid 23290880)
40. Sakoda LC, Blackston C, Doherty JA et al (2008) Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women. Cancer Epidemiol Biomarkers Prev 17:1066-1073
41. Kristensen VN, Andersen TI, Lindblom A, Erikstein B, Magnus P, Borresen-Dale AL (1998) A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics 8:43-48
42. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H (1996) Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11:306-311 (Pubitemid 26076380)
43. Sano M, Inoue S, Hosoi T et al (1995) Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 217:378-383 (Pubitemid 26060487)
44. Kristensen VN, Andersen TI, Erikstein B et al (1998) Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients. Pharmacogenetics 8:441-447 (Pubitemid 28475308)
45. Fryer AA, Zhao L, Alldersea J, Pearson WR, Strange RC (1993) Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A, B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus. Biochem J 295(Pt 1):313-315 (Pubitemid 23298343)
46. Kosoy R, Nassir R, Tian C et al (2009) Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat 30:69-78
47. Falush D, Stephens M, Pritchard JK (2003) Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164:1567-1587 (Pubitemid 37102217)
48. Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155:945-959 (Pubitemid 30397141)
49. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 57(1):289-300
50. Ng PC, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31:3812-3814 (Pubitemid 37442253)
51. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989 (Pubitemid 32289743)
52. National Center for Biotechnology Information (2009) Entrez SNP website
53. Wacholder S (1991) Practical considerations in choosing between the case-cohort and nested case-control designs. Epidemiol Res 2:155-158
54. Dunn BK, Agurs-Collins T, Browne D, Lubet R, Johnson KA (2010) Health disparities in breast cancer: biology meets socioeconomic status. Breast Cancer Res Treat 121:281-292
55. Rebbeck TR, Troxel AB, Shatalova EG et al (2007) Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 16:1318-1320 (Pubitemid 46984981)
56. Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF (1998) Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res 58:65-70 (Pubitemid 28027718)
57. Bailey LR, Roodi N, Dupont WD, Parl FF (1998) Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 58:5038-5041 (Pubitemid 28521155)
58. Le Marchand L, Donlon T, Kolonel LN, Henderson BE, Wilkens LR (2005) Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 14:1998-2003 (Pubitemid 41161214)
59. Liu J, Papasian C, Deng HW (2007) Incorporating single-locus tests into haplotype cladistic analysis in case-control studies. PLoS Genet 3:e46
60. The International HapMap Consortium (2003) The International HapMap Project Nature 426:789-796
61. MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Ris (2010) Postmenopausal estrogen monotherapy-associated breast cancer risk is modified by CYP17A1--34-T>C polymorphism. Breast Cancer Res Treat 120:737-744
62. Chen Y, Gammon MD, Teitelbaum SL et al (2008) Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project. Carcinogenesis 29:766-771 (Pubitemid 351494164)
63. Justenhoven C, Hamann U, Schubert F et al (2008) Breast cancer: a candidate gene approach across the estrogen metabolic pathway. Breast Cancer Res Treat 108:137-149 (Pubitemid 351623246)
64. Reding KW, Weiss NS, Chen C et al (2009) Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk. Cancer Epidemiol Biomarkers Prev 18:1461-1467
65. Diergaarde B, Potter JD, Jupe ER et al (2008) Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 17:1751-1759
66. Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF (2000) Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 60:3440-3444 (Pubitemid 30482162)
67. Goth-Goldstein R, Erdmann CA, Russell M (2003) Cytochrome P4501B1 expression in normal breast tissue, 23 ed. p. 275
68. Murray GI, Taylor MC, McFadyen MC et al (1997) Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57:3026-3031 (Pubitemid 27315056)
69. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D (2000) Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 27:75-93
70. Yager JD (2000) Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 27:67-73
71. de Jong MM, Nolte IM, te Meerman GJ et al (2002) Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 39:225-242 (Pubitemid 34496797)
72. Weiss LK, Burkman RT, Cushing-Haugen KL et al (2002) Hormone replacement therapy regimens and breast cancer risk. Obstet Gynecol 100:1148-1158 (Pubitemid 35449180)
73. Brentano ST, Picado-Leonard J, Mellon SH, Moore CC, Miller WL (1990) Tissue-specific, cyclic adenosine 3′,5′-monophosphate-induced, and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells. Mol Endocrinol 4:1972-1979
74. Ma H, Wang Y, Sullivan-Halley J et al (2009) Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports? Cancer Epidemiol Biomarkers Prev 18:2214-2220